{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:07:43Z","timestamp":1777381663241,"version":"3.51.4"},"reference-count":104,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This article presents a narrative review of psilocybin-assisted psychotherapy as a promising intervention for addressing anxiety, depression and psycho-existential distress in patients with advanced cancer. This group of disorders, often resistant to conventional treatments, significantly impacts patients\u2019 quality of life and autonomy, as well as illness trajectories. Psilocybin, when administered in high doses within a structured therapeutic framework, seems to alleviate these symptoms safely and effectively, with potential additional benefits on pain and systemic inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A targeted literature search was conducted across major scientific databases\u2014including PubMed, Scopus, PsycINFO, Cochrane Library and Embase\u2014supervised by experts from various relevant disciplines to identify sources of particular importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The process also led to the acquisition of highly cited scientific works to compose a coherent theoretical framework through which to interpret the evidence initially collected. Emerged key themes include: the complex and treatment-resistant nature of psycho-existential disorders in cancer; the importance of set, setting and peak experiences for psilocybin efficacy, as well as the consequent therapeutic value of integrated approaches that include psychotherapy; and the methodological limitations in more recent experimental trials. The article also identifies palliative care as a uniquely appropriate context for psilocybin-assisted psychotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>psilocybin-assisted psychotherapy is a compelling therapeutic option warranting further investigation through rigorous, interdisciplinary research to promote an anthropologically\/ethically grounded implementation in palliative settings, even beyond the oncology field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005689","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:20:16Z","timestamp":1771438816000},"page":"595-605","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-2021","authenticated-orcid":false,"given":"Luca","family":"Magnani","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7632-1271","authenticated-orcid":false,"given":"Luca","family":"Ghirotto","sequence":"additional","affiliation":[{"name":"Qualitative Research Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Fesce","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi I Sunyer (IDIBAPS), SJD Pediatric Cancer Center, Fundaci\u00f3 Cl\u00ednic per a la Recerca Biom\u00e8dica, Santa Rosa (Barcelona), Spain"},{"name":"Institut de Recerca Sant Joan de D\u00e9u, Fundaci\u00f3 Sant Joan de D\u00e9u, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Re","sequence":"additional","affiliation":[{"name":"Psy UNESCO Chair \u201cHealth Anthropology, Biosphere and Healing Systems\u201d, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-5064","authenticated-orcid":false,"given":"Silvia","family":"Tanzi","sequence":"additional","affiliation":[{"name":"Palliative Care Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-340X","authenticated-orcid":false,"given":"Andrea","family":"Amerio","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy"},{"name":"IRCCS Polyclinic Hospital San Martino, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Costanza","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland"},{"name":"Department of Psychiatry, Faculty of Biomedical Sciences, University of Italian Switzerland (USI), Lugano, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2026042802201383000_16.3.595.1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.141124"},{"key":"2026042802201383000_16.3.595.2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.02.012","article-title":"The global political economy of scheduling: the international-historical context of the Controlled Substances Act","volume":"76","author":"McAllister","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"2026042802201383000_16.3.595.3","doi-asserted-by":"crossref","DOI":"10.1038\/s44184-024-00068-9","article-title":"A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials","volume":"3","author":"Kishon","year":"2024","journal-title":"Npj Ment Health Res"},{"key":"2026042802201383000_16.3.595.4","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.103309"},{"key":"2026042802201383000_16.3.595.5","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1416420","article-title":"Psilocybin for major depressive disorder: a systematic review of randomized controlled studies","volume":"15","author":"Li","year":"2024","journal-title":"Front Psychiatry"},{"key":"2026042802201383000_16.3.595.6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"2026042802201383000_16.3.595.7","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1150080"},{"key":"2026042802201383000_16.3.595.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41429-020-0311-8"},{"key":"2026042802201383000_16.3.595.9","first-page":"91","article-title":"Psilocybin: a pharmacological profile","volume":"146","author":"Aboul-Enein","year":"1974","journal-title":"Am J Pharm Sci Support Public Health"},{"key":"2026042802201383000_16.3.595.10","doi-asserted-by":"publisher","DOI":"10.1007\/BF02160424"},{"key":"2026042802201383000_16.3.595.11","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S443177"},{"key":"2026042802201383000_16.3.595.12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.5306\/wjco.v15.i7.908","article-title":"Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis","volume":"15","author":"Bader","year":"2024","journal-title":"World J Clin Oncol"},{"key":"2026042802201383000_16.3.595.13","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2024-105532"},{"key":"2026042802201383000_16.3.595.14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2793-5"},{"key":"2026042802201383000_16.3.595.15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S2215-0366(23)00179-7","article-title":"Mental disorders, participation, and trajectories in the Danish colorectal cancer programme: a population-based cohort study","volume":"10","author":"Thomsen","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"2026042802201383000_16.3.595.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101155","article-title":"Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline","volume":"8","author":"Grassi","year":"2023","journal-title":"ESMO Open"},{"key":"2026042802201383000_16.3.595.17","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1097\/NCC.0000000000000925","article-title":"Existential Distress in Cancer Patients: A Concept Analysis","volume":"45","author":"Chen","year":"2022","journal-title":"Cancer Nurs"},{"key":"2026042802201383000_16.3.595.18","doi-asserted-by":"crossref","unstructured":"Pyszczynski TK , Lockett MA . A terror management theory perspective on human motivation. In: The Oxford handbook of human motivation. 2nd edn. Oxford University Press, 2019: 67\u201388.","DOI":"10.1093\/oxfordhb\/9780190666453.013.5"},{"key":"2026042802201383000_16.3.595.19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/00302228221107723","article-title":"Application of Terror Management Theory to End-Of-Life Care Decision-Making: A Narrative Literature Review","volume":"90","author":"Perry","year":"2024","journal-title":"Omega (Westport)"},{"key":"2026042802201383000_16.3.595.20","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.30025","article-title":"The relationship between coping strategies, quality of life, and mood in patients with incurable cancer","volume":"122","author":"Nipp","year":"2016","journal-title":"Cancer"},{"key":"2026042802201383000_16.3.595.21","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328340775e"},{"key":"2026042802201383000_16.3.595.22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/pon.5103","article-title":"Psychosocial interventions for advanced cancer patients: A systematic review","volume":"28","author":"Teo","year":"2019","journal-title":"Psychooncology"},{"key":"2026042802201383000_16.3.595.23","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"3","author":"Vita","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026042802201383000_16.3.595.24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report","volume":"163","author":"Rush","year":"2006","journal-title":"AJP"},{"key":"2026042802201383000_16.3.595.25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jamapsychiatry.2023.2983","article-title":"Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis","volume":"80","author":"K\u00f6hler-Forsberg","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2026042802201383000_16.3.595.26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/pon.4048","article-title":"A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients","volume":"25","author":"Sanjida","year":"2016","journal-title":"Psychooncology"},{"key":"2026042802201383000_16.3.595.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.07.005"},{"key":"2026042802201383000_16.3.595.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjon.2024.100610","article-title":"Time toxicity in cancer care: A concept analysis using Walker and Avant\u2019s method","volume":"11","author":"Nwozichi","year":"2024","journal-title":"Asia Pac J Oncol Nurs"},{"key":"2026042802201383000_16.3.595.29","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13541"},{"key":"2026042802201383000_16.3.595.30","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2016_459\/COVER"},{"key":"2026042802201383000_16.3.595.31","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-024-03187-1","article-title":"Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology","volume":"14","author":"Shinozuka","year":"2024","journal-title":"Transl Psychiatry"},{"key":"2026042802201383000_16.3.595.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04768.x"},{"key":"2026042802201383000_16.3.595.33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2830-16.2016"},{"key":"2026042802201383000_16.3.595.34","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2821"},{"key":"2026042802201383000_16.3.595.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-0718-8"},{"key":"2026042802201383000_16.3.595.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2023.01.003"},{"key":"2026042802201383000_16.3.595.37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature New Biol"},{"key":"2026042802201383000_16.3.595.38","doi-asserted-by":"crossref","DOI":"10.1038\/srep46421","article-title":"Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin","volume":"7","author":"Schartner","year":"2017","journal-title":"Sci Rep"},{"key":"2026042802201383000_16.3.595.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119220","article-title":"Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex","volume":"256","author":"Girn","year":"2022","journal-title":"Neuroimage"},{"key":"2026042802201383000_16.3.595.40","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyac074"},{"key":"2026042802201383000_16.3.595.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.04.023"},{"key":"2026042802201383000_16.3.595.42","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-022-01822-4","article-title":"The Altered States Database: Psychometric data from a systematic literature review","volume":"9","author":"Prugger","year":"2022","journal-title":"Sci Data"},{"key":"2026042802201383000_16.3.595.43","doi-asserted-by":"crossref","unstructured":"Costines C , Schmidt TT . Phenomenology of Psychedelic Experiences and Psychedelic-Associated Distressing Effects: Quantifying Subjective Experiences. Curr Top Behav Neurosci 2024. doi:10.1007\/7854_2024_562","DOI":"10.1007\/7854_2024_562"},{"key":"2026042802201383000_16.3.595.44","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231172254","article-title":"The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics","volume":"13","author":"Evens","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026042802201383000_16.3.595.45","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13741"},{"key":"2026042802201383000_16.3.595.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-5906.2012.01685.x"},{"key":"2026042802201383000_16.3.595.47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J Psychopharmacol"},{"key":"2026042802201383000_16.3.595.48","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2017.00245","article-title":"Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution","volume":"11","author":"Milli\u00e8re","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"2026042802201383000_16.3.595.49","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2016.00269","article-title":"Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)","volume":"10","author":"Nour","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"2026042802201383000_16.3.595.50","first-page":"520","article-title":"Patients\u2019 Accounts of Increased \u201cConnectedness\u201d and \u201cAcceptance\u201d After Psilocybin for Treatment-Resistant Depression","volume":"57","author":"Watts","year":"2017","journal-title":"J Hum Psychol"},{"key":"2026042802201383000_16.3.595.51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79931-w","article-title":"Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study","volume":"14","author":"Wood","year":"2024","journal-title":"Sci Rep"},{"key":"2026042802201383000_16.3.595.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.073"},{"key":"2026042802201383000_16.3.595.53","doi-asserted-by":"crossref","unstructured":"Argyri EK , Evans J , Luke D , et al . Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences. SSRN Journal 2024. doi:10.2139\/ssrn.4817368","DOI":"10.2139\/ssrn.4817368"},{"key":"2026042802201383000_16.3.595.54","doi-asserted-by":"publisher","DOI":"10.1017\/S0007125000072986"},{"key":"2026042802201383000_16.3.595.55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01209-2","article-title":"Psychedelics alter metaphysical beliefs","volume":"11","author":"Timmermann","year":"2021","journal-title":"Sci Rep"},{"key":"2026042802201383000_16.3.595.56","doi-asserted-by":"crossref","first-page":"729425","DOI":"10.3389\/fpsyg.2021.729425","article-title":"Sociality, and Human Evolution","volume":"12","author":"Rodriguez Arce","year":"2021","journal-title":"Front Psychol"},{"key":"2026042802201383000_16.3.595.57","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/02791072.2023.2228303","article-title":"Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences","volume":"56","author":"Low","year":"2024","journal-title":"J Psychoactive Drugs"},{"key":"2026042802201383000_16.3.595.58","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front Psychiatry"},{"key":"2026042802201383000_16.3.595.59","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997"},{"key":"2026042802201383000_16.3.595.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2020.11.008"},{"key":"2026042802201383000_16.3.595.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01744-z"},{"key":"2026042802201383000_16.3.595.62","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211026454"},{"key":"2026042802201383000_16.3.595.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.12.041"},{"key":"2026042802201383000_16.3.595.64","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.710004","article-title":"Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy","volume":"15","author":"Lepow","year":"2021","journal-title":"Front Neurosci"},{"key":"2026042802201383000_16.3.595.65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2026042802201383000_16.3.595.66","doi-asserted-by":"crossref","first-page":"106086","DOI":"10.1016\/j.neubiorev.2025.106086","article-title":"The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis","volume":"172","author":"Romeo","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"2026042802201383000_16.3.595.67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/02698811241312866","article-title":"Catalyst for change: Psilocybin\u2019s antidepressant mechanisms-A systematic review","volume":"39","author":"Liebnau","year":"2025","journal-title":"J Psychopharmacol"},{"key":"2026042802201383000_16.3.595.68","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/jpm.2022.0036","article-title":"Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness","volume":"25","author":"Rosa","year":"2022","journal-title":"J Palliat Med"},{"key":"2026042802201383000_16.3.595.69","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/cncr.35024","article-title":"Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis","volume":"130","author":"Beaussant","year":"2024","journal-title":"Cancer"},{"key":"2026042802201383000_16.3.595.70","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/inm.13127","article-title":"Experiences of psilocybin treatment for clinical conditions: A qualitative meta\u2010synthesis","volume":"32","author":"Crowe","year":"2023","journal-title":"Int J Mental Health Nurs"},{"key":"2026042802201383000_16.3.595.71","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1176\/appi.psychotherapy.20200055","article-title":"Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy","volume":"74","author":"Horton","year":"2021","journal-title":"Am J Psychother"},{"key":"2026042802201383000_16.3.595.72","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1439347","article-title":"The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis","volume":"15","author":"Chen","year":"2024","journal-title":"Front Psychiatry"},{"key":"2026042802201383000_16.3.595.73","doi-asserted-by":"publisher","DOI":"10.1124\/pr.118.017160"},{"key":"2026042802201383000_16.3.595.74","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROPHARM.2018.03.010"},{"key":"2026042802201383000_16.3.595.75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-28111-3","article-title":"From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)","volume":"15","author":"Zeifman","year":"2025","journal-title":"Sci Rep"},{"key":"2026042802201383000_16.3.595.76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000467984","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"Int Pharmacopsychiatry"},{"key":"2026042802201383000_16.3.595.77","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1213\/00000539-196405000-00013","article-title":"Study of Lysergic Acid Diethylamide as an Analgesic Agent","volume":"43","author":"Kast","year":"1964","journal-title":"Anesthesia & Analgesia"},{"key":"2026042802201383000_16.3.595.78","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"2026042802201383000_16.3.595.79","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"2026042802201383000_16.3.595.80","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"2026042802201383000_16.3.595.81","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119897615"},{"key":"2026042802201383000_16.3.595.82","first-page":"488","article-title":"Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress","volume":"57","author":"Swift","year":"2017","journal-title":"J Hum Psychol"},{"key":"2026042802201383000_16.3.595.83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2026042802201383000_16.3.595.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2023.06.006"},{"key":"2026042802201383000_16.3.595.85","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jad.2022.11.046","article-title":"Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients","volume":"323","author":"Shnayder","year":"2023","journal-title":"J Affect Disord"},{"key":"2026042802201383000_16.3.595.86","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"Agrawal","year":"2024","journal-title":"Cancer"},{"key":"2026042802201383000_16.3.595.87","article-title":"Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases","volume":"9","author":"Schipper","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"2026042802201383000_16.3.595.88","doi-asserted-by":"crossref","first-page":"2698811241303594","DOI":"10.1177\/02698811241303594","article-title":"Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis","volume":"2024","author":"Marchi","year":"2024","journal-title":"J Psychopharmacol"},{"key":"2026042802201383000_16.3.595.89","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-06027-y"},{"key":"2026042802201383000_16.3.595.90","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5960","article-title":"Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis","volume":"7","author":"Yerubandi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026042802201383000_16.3.595.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.05.012"},{"key":"2026042802201383000_16.3.595.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115880"},{"key":"2026042802201383000_16.3.595.93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/02698811231215420","article-title":"Older adults in psychedelic-assisted therapy trials: A systematic review","volume":"38","author":"Bouchet","year":"2024","journal-title":"J Psychopharmacol"},{"key":"2026042802201383000_16.3.595.94","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"The Lancet"},{"key":"2026042802201383000_16.3.595.95","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078607","article-title":"Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis","volume":"386","author":"Hsu","year":"2024","journal-title":"BMJ"},{"key":"2026042802201383000_16.3.595.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.112749"},{"key":"2026042802201383000_16.3.595.97","doi-asserted-by":"crossref","first-page":"116337","DOI":"10.1016\/j.psychres.2024.116337","article-title":"Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials","volume":"344","author":"Swieczkowski","year":"2025","journal-title":"Psychiatry Res"},{"key":"2026042802201383000_16.3.595.98","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1481827"},{"key":"2026042802201383000_16.3.595.99","doi-asserted-by":"crossref","first-page":"107699","DOI":"10.1016\/j.phrs.2025.107699","article-title":"IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain","volume":"215","author":"Koseli","year":"2025","journal-title":"Pharmacol Res"},{"key":"2026042802201383000_16.3.595.100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/cpt.2487","article-title":"Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double\u2010Blind, Placebo\u2010Controlled, Crossover Study in Healthy Subjects","volume":"111","author":"Becker","year":"2022","journal-title":"Clin Pharma and Therapeutics"},{"key":"2026042802201383000_16.3.595.101","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cpt.3618","article-title":"Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial","volume":"117","author":"Becker","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"2026042802201383000_16.3.595.102","doi-asserted-by":"crossref","unstructured":"Hartogsohn I . Constructing drug effects: A history of set and setting. Drug Science, Policy and Law 2017;3. doi:10.1177\/2050324516683325","DOI":"10.1177\/2050324516683325"},{"key":"2026042802201383000_16.3.595.103","doi-asserted-by":"crossref","first-page":"102997","DOI":"10.1016\/j.drugpo.2020.102997","article-title":"Making \u201cbad trips\u201d good: How users of psychedelics narratively transform challenging trips into valuable experiences","volume":"87","author":"Gashi","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2026042802201383000_16.3.595.104","unstructured":"(FDA) USFaDA . Psychedelic drugs: considerations for clinical investigations. Research CfDEa; 2023."}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:21:21Z","timestamp":1777368081000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":104,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/spcare-2025-005689"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005689","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}